-
2
-
-
33344458573
-
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
-
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4: 295-306.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 295-306
-
-
Miyakis, S.1
Lockshin, M.D.2
Atsumi, T.3
Branch, D.W.4
Brey, R.L.5
Cervera, R.6
-
3
-
-
0025332717
-
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: Beta 2-glycoprotein I (apolipoprotein H)
-
McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA. 1990; 87: 4120-4.
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, pp. 4120-4124
-
-
McNeil, H.P.1
Simpson, R.J.2
Chesterman, C.N.3
Krilis, S.A.4
-
4
-
-
0022202567
-
Interaction of beta 2-glycoprotein-I with human blood platelets: Influence upon ADP-induced aggregation
-
Nimpf J, Wurm H, Kostner GM. Interaction of beta 2-glycoprotein-I with human blood platelets: influence upon ADP-induced aggregation. Thromb Haemost. 1985; 54: 397-401.
-
(1985)
Thromb Haemost
, vol.54
, pp. 397-401
-
-
Nimpf, J.1
Wurm, H.2
Kostner, G.M.3
-
5
-
-
0022202304
-
Beta-2 glycoprotein I: A plasma inhibitor of the coontact activation of the intrinsic blood coagulation pathway
-
Schousboe I. Beta-2 glycoprotein I: a plasma inhibitor of the coontact activation of the intrinsic blood coagulation pathway. Blood. 1985; 66: 1086-91.
-
(1985)
Blood
, vol.66
, pp. 1086-1091
-
-
Schousboe, I.1
-
6
-
-
33747023522
-
Anti-62-glycoprotein I antibodies in complex with t2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IXV
-
Shi T, Giannakopoulos B, Yan X, et al. Anti-62-glycoprotein I antibodies in complex with t2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IXV. Arthritis Rheum. 2006; 54: 2558-67.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 2558-2567
-
-
Shi, T.1
Giannakopoulos, B.2
Yan, X.3
-
7
-
-
47649130477
-
Platelet activation by dimeric β2-glycoprotein I requires signaling via both glycoprotein Ibα and apoliprotein E receptor 2'
-
Urbanus RT, Pennings MT, Derksen RHWM, et al. Platelet activation by dimeric β2-glycoprotein I requires signaling via both glycoprotein Ibα gand apoliprotein E receptor 2'. J Thromb Haemost. 2008; 6: 1405-12.
-
(2008)
J Thromb Haemost
, vol.6
, pp. 1405-1412
-
-
Urbanus, R.T.1
Pennings, M.T.2
Derksen, R.H.W.M.3
-
8
-
-
79958086576
-
Pathogenesis of antiphospholipid syndrome: Understanding the antibodies
-
Meroni PL, Borghi MO, Raschi E, et al. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 2011; 7: 330-9.
-
(2011)
Nat Rev Rheumatol
, vol.7
, pp. 330-339
-
-
Meroni, P.L.1
Borghi, M.O.2
Raschi, E.3
-
9
-
-
0031594156
-
Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: Association with increased excretion of platelet-derived thromboxane urinary metabolites
-
Forastiero R, Martinuzzo M, Carreras LO, Maclouf J. Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites. Thromb Haemost. 1998; 79: 42-5.
-
(1998)
Thromb Haemost
, vol.79
, pp. 42-45
-
-
Forastiero, R.1
Martinuzzo, M.2
Carreras, L.O.3
McLouf, J.4
-
10
-
-
37749045374
-
Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies
-
Jy W, Tiede M, Bidot CJ, Horstman LL, Jimenez JJ, Chirinos J, Ahn YS. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies. Thromb Res. 2007; 121: 319-25.
-
(2007)
Thromb Res
, vol.121
, pp. 319-325
-
-
Jy, W.1
Tiede, M.2
Bidot, C.J.3
Horstman, L.L.4
Jimenez, J.J.5
Chirinos, J.6
Ahn, Y.S.7
-
11
-
-
45849104308
-
Platelets and atherosclerosis
-
In: Gresele P, Fuster V, Lopez J, Page CP, Vermylen J. eds Cambridge University press, Cambridge, UK
-
Lindemann S, Gawaz M. Platelets and atherosclerosis. In: Gresele P, Fuster V, Lopez J, Page CP, Vermylen J. Platelets in cardiovascular and hemorrhagic disorders: a clinical handbook. eds Cambridge University press, Cambridge, UK. 2007: 293-307.
-
(2007)
Platelets in cardiovascular and hemorrhagic disorders: A clinical handbook
, pp. 293-307
-
-
Lindemann, S.1
Gawaz, M.2
-
12
-
-
14944384692
-
Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation
-
Pitchford SC, Momi S, Giannini S, Casali L, Spina D, Page CP, Gresele P. Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation. Blood. 2005; 105: 2074-81.
-
(2005)
Blood
, vol.105
, pp. 2074-2081
-
-
Pitchford, S.C.1
Momi, S.2
Giannini, S.3
Casali, L.4
Spina, D.5
Page, C.P.6
Gresele, P.7
-
13
-
-
28444487916
-
Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation
-
Falcinelli E, Guglielmini G, Torti M, Gresele P. Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation. J Thromb Haemost. 2005; 3: 2526-35.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 2526-2535
-
-
Falcinelli, E.1
Guglielmini, G.2
Torti, M.3
Gresele, P.4
-
14
-
-
34250817676
-
Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: Lack of inhibition by aspirin
-
Falcinelli E, Giannini S, Boschetti E, Gresele P. Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin. Br J Haematology. 2007; 138: 221-230.
-
(2007)
Br J Haematology
, vol.138
, pp. 221-230
-
-
Falcinelli, E.1
Giannini, S.2
Boschetti, E.3
Gresele, P.4
-
15
-
-
0032484987
-
CD40L on activated platelets triggers an inflammatory reaction of endothelial cells
-
Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA. CD40L on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998; 391: 591-4.
-
(1998)
Nature
, vol.391
, pp. 591-594
-
-
Henn, V.1
Slupsky, J.R.2
Grafe, M.3
Anagnostopoulos, I.4
Forster, R.5
Muller-Berghaus, G.6
Kroczek, R.A.7
-
16
-
-
31044436262
-
Platelets in inflammation and atherogenesis
-
Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005; 115: 3378-84.
-
(2005)
J Clin Invest
, vol.115
, pp. 3378-3384
-
-
Gawaz, M.1
Langer, H.2
May, A.E.3
-
17
-
-
0033586656
-
Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo
-
Pierangeli SS, Colden-Stanfield M, Liu X, et al. Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation. 1999; 99: 1997-2002.
-
(1999)
Circulation
, vol.99
, pp. 1997-2002
-
-
Pierangeli, S.S.1
Colden-Stanfield, M.2
Liu, X.3
-
18
-
-
0028883356
-
Activation of cultured vascular endothelial cells by antiphospholipid antibodies
-
Simantov R, La Sala JM, Lo SK, et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J Clin Invest. 1995; 96: 2211-9.
-
(1995)
J Clin Invest
, vol.96
, pp. 2211-2219
-
-
Simantov, R.1
la Sala, J.M.2
Lo, S.K.3
-
19
-
-
13244292209
-
Proposal for the measurement of anti-b2-Glycoprotein I antibodies
-
Standardization Group of the European Forum on Antiphospholipid Antibodies
-
Reber G, Tincani A, Sanmarco M, de Moerloose P, Boffa MC. Proposal for the measurement of anti-b2-Glycoprotein I antibodies. Standardization Group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost. 2004; 2: 1860-2.
-
(2004)
J Thromb Haemost
, vol.2
, pp. 1860-1862
-
-
Reber, G.1
Tincani, A.2
Sanmarco, M.3
de Moerloose, P.4
Boffa, M.C.5
-
20
-
-
27144494245
-
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor
-
Fischetti F, Durigutto P, Pellis V, Debeus A, Macor P, Bulla R, et al. Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. Blood. 2005; 106: 2340-6.
-
(2005)
Blood
, vol.106
, pp. 2340-2346
-
-
Fischetti, F.1
Durigutto, P.2
Pellis, V.3
Debeus, A.4
Macor, P.5
Bulla, R.6
-
21
-
-
42649140592
-
Role of infectious agents in systemic rheumatic diseases
-
Amital H, Govoni M, Maya R, Meroni PL, Ori B, Shoenfeld Y, et al. Role of infectious agents in systemic rheumatic diseases. Clin Exp Rheumatol. 2008; 26 (Suppl.): S27-32.
-
(2008)
Clin Exp Rheumatol.
, vol.26
, Issue.SUPPL.
-
-
Amital, H.1
Govoni, M.2
Maya, R.3
Meroni, P.L.4
Ori, B.5
Shoenfeld, Y.6
-
22
-
-
29144479891
-
Infectious origin of the antiphospholipid syndrome
-
Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis. 2006; 65: 2-6.
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 2-6
-
-
Shoenfeld, Y.1
Blank, M.2
Cervera, R.3
Font, J.4
Raschi, E.5
Meroni, P.L.6
|